AMP kinase-induced skeletal muscle glucose but not long-chain fatty acid uptake is dependent on nitric oxide

Diabetes

Volumn 53, Issue 6, 2004, Pages 1429-1435

  Shearer, Jane ^a   Fueger, Patrick T ^a   Vorndick, Brittney ^a   Bracy, Deanna P ^a   Rottman, Jeffery N ^a   Clanton, Jeffery A ^a   Wasserman, David H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL)PENTADECANOIC ACID I 125; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; DEOXYGLUCOSE; DEOXYGLUCOSE H 3; GLUCOSE; INTRALIPID; LONG CHAIN FATTY ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CATHETER; ENZYME ACTIVATION; FATTY ACID TRANSPORT; GASTROCNEMIUS MUSCLE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; JUGULAR VEIN; MALE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; VASTUS LATERALIS MUSCLE;

ADENYLATE KINASE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; BLOOD GLUCOSE; ENZYME ACTIVATION; ENZYME INHIBITORS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; IMMUNOBLOTTING; INSULIN; KINETICS; MALE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEOTIDES;

EID: 2542632870     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.6.1429     Document Type: Article

References (52)

1. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 106:473-481, 2000
2. Kelley D, Mandarino L: Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677-683, 2000
3. Winder WW, Hardie DG: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol Endocrinol Metab 277:E1-E10, 1999
4. Hardie DG, Pan DA: Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30:1064-1070, 2002
5. Winder WW, Hardie DG: Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol Endocrinol Metab 270:E299-E304, 1996
6. Fryer LGD, Parbu-Patel A, Carling D: Protein kinase inhibitors block the stimulation of the AMP-activated protein kinase by 5-amino-4-imidazole-carboxamide riboside. FEBS Lett 531:189-192, 2002
7. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174, 2001
8. Steinberg GR, Rush JWE, Dyck DJ: AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am J Physiol Endocrinol Metab 284:E648-E654, 2003
9. Yamauchi T, Kamon Y, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura R, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated kinase. Nat Med 8:1288-1295, 2002
10. Morrow VA, Foufelle F, Connell JMC, Petrie JR, Gould GW, Salt IP: Direct activation of AMP-activated protein kinase stimulates nitric oxide synthesis in human aortic endothelial cells. J Biol Chem 278:31629-31639, 2003
11. Fryer L, Hajduch E, Rencurel F, Salt I, Hundal H, Hardie D, Carling D: Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes 49:1978-1985, 2000
12. Balon TW, Nadler JL: Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 77:2519-2521, 1994
13. Balon TW, Nadler JL: Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 82:359-363, 1997
14. Roy D, Perreault M, Marette A: Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol Endocrinol Metab 274:E692-E699, 1998
15. Kingwell BA, Formosa M, Muhlmann M, Bradley SJ, McConell GK: Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. Diabetes 51:2572-2580, 2002
16. Etgen G, Fryburg D, Gibbs E: Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 46:1915-1919, 1997
17. Baron AD, Zhu JS, Marshall S, Irsula O, Brechtel G, Keech C: Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am J Physiol Endocrinol Metab 269:E709-E715, 1995
18. Winder WW, Hardie DG: Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 270:E299-E304, 1996
19. Petersen HA, Fueger PT, Bracy DP, Wasserman DH, Halseth AE: Fiber type-specific determinants of Vmax for insulin-stimulated muscle glucose uptake in vivo. Am J Physiol Endocrinol Metab 284:E541-E548, 2003
20. Zatz R, Baylis C: Chronic nitric oxide inhibition model six years on. Hypertension 32:958-964, 1998
21. Arnal JF, Warin L, Michel JB: Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 90:647-652, 1992
22. Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE: Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation 104:839-844, 2001
23. Bernstein R, Ochoa F, Xu X, Forfia P, Shen W, Thompson C, Hintze T: Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res 79:840-848, 1996
24. Armstrong RB, Phelps RO: Muscle fiber type composition of the rat hindlimb. Am J Anat 171:259-272, 1984
25. Morgan CR, Lazarow AL: Immunoassay of insulin: two antibody system: plasma insulin of normal, subdiabetic, and diabetic rats. Am J Med Sci 257:415-419, 1963
26. Dyck DJ, Putman CT, Heigenhauser GJ, Hultman E, Spriet LL: Regulation of fat-carbohydrate interaction in skeletal muscle during intense aerobic cycling. Am J Physiol Endocrinol Metab 265:E852-E859, 1993
27. Hargreaves M, Kiens B, Richter EA: Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising men. J Appl Physiol 70:194-201, 1991
28. Rottman JN, Bracy D, Malabanan C, Yue Z, Clanton J, Wasserman DH: Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Am J Physiol Endocrinol Metab 283:E116-E123, 2002
29. Halseth AE, Bracy DP, Wasserman DH: Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat. Am J Physiol Endocrinol Metab 279:E1064-E1071, 2000
30. Meszaros K, Bagby GJ, Lang CH, Spitzer JJ: Increased uptake and phosphorylation of 2-deoxyglucose by skeletal muscles in endotoxin-treated rats. Am J Physiol Endocrinol Metab 253:E33-E39, 1987
31. Mezaros K, Lang CH, Hargrove DM, Spitzer JJ: Tissue glucose utilization during epinephrine induced hyperglycemia. J Appl Physiol 67:1770-1775, 1989
32. 14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: impliactions for the quantitation of tissue glucose uptake. Diabetes 46:1106-1110, 1997
33. Furler SM, Jenkins AB, Kraegen EW: Effect of insulin on [3H]deoxy-D-glucose pharmacokinetics in the rat. Am J Physiol 255:E806-E811, 1988
34. Kraegen EW, James DE, Jenkins AB, Chisholm DJ: Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E353-E362, 1985
35. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abunuad NA: Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275:32523-32529, 2000
36. Balent B, Goswami G, Goodloe G, Rogatsky E, Rauta O, Nezami R, Mints L, Angeletti R, Stein D: Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Ann N Y Acad Sci 967:535-543, 2002
37. Young ME, Radda GK, Leighton B: Nitric Oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem J 322:223-228, 1997
38. Russell RR III, Bergeron R, Shulman GI, Young LH: Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol Heart Circ Physiol 277:H643-H649, 1999
39. Stamler JS, Meissner G: Physiology of nitric oxide in skeletal muscle. Physiol Rev 81:209-237, 2001
40. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE: AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289, 1999
41. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE: AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279:E1202-E1206, 2000
42. Michell BJ, Chen Z, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, Kemp BE: Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276:17625-17628, 2001
43. Harris MB, Ju H, Venema VJ, Liang H, Zou R, Michell BJ, Chen ZP, Kemp BE, Venema RC: Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 276:16587-16591, 2001
44. Butt E, Bernhardt M, Smolenski A, Kotsonis P, Frohlich LG, Sickmann A, Meyer HE, Lokmann SM, Schmidt HH: Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem 275:5179-5187, 2000
45. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605, 1999
46. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601, 1999
47. Luiken JJFP, Coort SLM, Willems J, Coumans WA, Bonen A, van der Vusse GJ, Glatz JFC: Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52:1627-1634, 2003
48. Ruderman NB, Saha AK, Vavvas D, Witters LA: Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 276:E1-E18, 1999
49. Saha AK, Schwarsin AJ, Roduit R, Masse F, Kaushik V, Tornheim K, Prentki M, Ruderman NB: Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. J Biol Chem 275:24279-24283, 2000
50. Jessen N, Pold R, Buhl ES, Jensen LS, Schraitz O, Lund S: Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 94:1373-1379, 2003
51. Ai H, Ihlemann J, Hellsten Y, Lauritzen HPMM, Hardie DG, Galbo H, Ploug T: Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle. Am J Physiol Endocrinol Metab 282:E1291-E1300, 2002
52. Bonen A, Dyck DJ, Luiken JJFP: Skeletal muscle fatty acid transport and transporters. In Skeletal Muscle Metabolism in Exercise and Diabetes. Richter EA, Kien B, Galbo H, Saltin B, Eds. New York, Plenum Press, 1998, p. 181-205